Rubella vaccine HPV77DE5 provided sustained antibody titres in most girls four years post-immunization. Reinfection rates were low, and rubella reinfection during pregnancy poses no known risk to the unborn child.
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Area of Science:
Context:
Purpose:
Summary:
Impact: